- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03731143
Management of Lower Punctal Stenosis.
A Simple Surgical Approach for the Management of Acquired Severe Lower Punctual Stenosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective non-randomized study which was conducted upon 24 patients with total lower punctual occlusion attending at Menoufia University hospitals in the period from January 2014 to January 2018. Ethics approval from the institutional review board was obtained, and a written informed consent was taken from every patient according to the Declaration of Helsinki.
All patients of the study were complaining of epiphora and had a thorough ophthalmological examination including dye disappearance test, and slit-lamp examination. The dye disappearance test was performed with a drop of 2% fluorescein sodium and assessment after 5 minutes of the remaining dye in the tear meniscus was done and results were graded.
Surgical procedure
All operations were done under general anesthesia and were performed by two authors (SSM, KES). The authors performed lacrimal probing and syringing test through the normal punctum to exclude concomitant occluded common canaliculus or nasolacrimal duct. The pigtail probe was passed through the canalicular system from the normal punctum to the occluded aspect. When the tip of the pigtail probe was positioned near the occluded punctal area, the surgeon pushed the area to be tented with the pigtail probe. After they advanced the pigtail probe back and forth several times until they could locate the correct position of the occluded punctum, the authors incised the tented area with a scalpel No. 11 to make a new punctal opening.
To ensure punctal and canalicular patency, syringing was repeated through the perforated punctum. To prevent re-occlusion of punctal opening, a self retaining bicanalicular tube (FCI®; Paris, France) was inserted through the normal and perforated puncti.
The silicone tube was left in place for 6 months before it was removed. Patients were then followed up for 1 year after the surgery (6 months after removal of the tube). During the follow-up period, the authors investigated the improvement of subjective epiphora symptoms based on Munk score, fluorescein disappearance test, maintenance of newly formed punctal opening, and incidence of complications.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- severe lowee punctual stenosis
- patent upper punctum and canaliculus as well as patent nasolacrimal duct
- normal lower eyelid margin position -
Exclusion Criteria:
- patients with punctal stenosis with grades more than 0 according to Kashkouli scale
- patients with previous eyelid surgery
- a lump overlying or involving the punctum or other part of the tear drainage system.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: study arm
surgical opening the lower punctum using the pig tail probe and a scalpel followed by insertion of self retaining bicanalicular stent (FCI®; Paris, France).
|
The pigtail probe was passed through the canalicular system from the normal punctum to the occluded aspect. When the tip of the pigtail probe was positioned near the occluded punctal area, the surgeon pushed the area to be tented with the pigtail probe. After they advanced the pigtail probe back and forth several times until they could locate the correct position of the occluded punctum, the authors incised the tented area with a scalpel No. 11 to make a new punctal opening. To ensure punctal and canalicular patency, syringing was repeated through the perforated punctum. To prevent re-occlusion of punctal opening, a self retaining bicanalicular tube (FCI®; Paris, France) was inserted through the normal and perforated puncti |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of improvement of epiphora by Munk score
Time Frame: 1 year
|
Measurement of improvement of epiphora by use of Munk score as follow Grade Clinical finding 0 No Epiphora.
|
1 year
|
Degree of improvement of lacrimal drainage by Dye disappearance test
Time Frame: 1 year
|
measurement of improvement by using the dye disappearance test. It was performed by putting a drop of 2% fluorescein sodium in the conjunctival sac followed by assessment after 5 minutes of the remaining dye in the tear meniscus. Results were graded according to the following scale Grade Dye disappearance time, min
|
1 year
|
Slit lamp assesment of the state of the lower punctum
Time Frame: 1 year
|
Slit lamp examination of the lower punctum and its grading according to Kashkouli scale as follows: Grade Clinical Findings 0 No punctum (agenesis)
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sameh S Mandour, MD, Menoufia Fculty of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 446H/2013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epiphora
-
Istanbul UniversityCompletedFunctional Epiphora (Tearing Without Any Anatomical Block)Canada, Turkey
-
Tianjin Medical University Cancer Institute and...RecruitingEpiphora Due to Insufficient Drainage, Left Side | Epiphora Due to Insufficient Drainage, Right SideChina
-
Tanta UniversityCompleted
-
AurolabCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Sinopsys SurgicalCompleted
-
Merbs, Shannath, M.D., Ph.D.CompletedEpiphoraUnited States
-
Menoufia UniversityActive, not recruitingEpiphora | Dacryocystitis | DacryocystoceleEgypt
-
Louisiana State University Health Sciences Center...RecruitingEpiphora | Dacryostenosis | DacryocystitisUnited States
-
Minia UniversityCompleted
Clinical Trials on insertion of self retaining bicanalicular stent
-
Minia UniversityUnknown
-
Yonsei UniversityUnknownColorectal CancerKorea, Republic of
-
Tampere University HospitalCompletedBiliary Tract DiseasesFinland
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedDysfunction of the Prosthetic Conduct | Lesions of the Right Ventricular Outflow TractFrance
-
Ajou University School of MedicineCompletedMalignant Distal Biliary StrictureKorea, Republic of
-
Theresienkrankenhaus und St. Hedwig-Klinik GmbHUniversitätsmedizin MannheimCompletedBile Duct Obstruction | Extrahepatic CholestasisGermany
-
University Hospital TuebingenUnknownIntervention | Cronic Limb IshemiaGermany
-
Flanders Medical Research ProgramCompletedPeripheral Arterial DiseaseBelgium
-
Ajou University School of MedicineCompletedGastroduodenal AnastomosisKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCompletedPancreatic Cancer | Unresectable Biliary-pancreatic MalignanciesUnited States